A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A).

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Steroid Biochemistry and Molecular Biology

• Publication date

  2014-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jsbmb.2014.05.007PMID 24861265
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo

  2014cited by this paper
• Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.

  2013cited by this paper
• Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy.

  2013cited by this paper
• Structural features discriminate androgen receptor N/C terminal and coactivator interactions.

  2012cited by this paper
• Evidence for DNA-Binding Domain–Ligand-Binding Domain Communications in the Androgen Receptor

  2012cited by this paper
• Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

  2012cited by this paper
• Hormonal contraception and the risk of HIV acquisition among women in South Africa

  2012cited by this paper
• olecular mechanisms of steroid receptor-mediated actions by synthetic rogestins used in HRT and contraception

  2011cited by this paper
• Androgen receptor signaling in prostate cancer development and progression

  2011cited by this paper
• Hormonal Contraception and HIV‐1 Transmission

  2011cited by this paper
• Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract.

  2011cited by this paper
• Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications

  2010cited by this paper
• Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor*♦

  2010cited by this paper
• DNA Binding Site Sequence Directs Glucocorticoid Receptor Structure and Activity

  2009cited by this paper
• Comprar Androgen Action in Prostate Cancer | Tindall, Donald | 9780387691770 | Springer

  2009cited by this paper
• Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.

  2009cited by this paper
• Androgen Action in Prostate Cancer

  2009cited by this paper
• Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.

  2008cited by this paper
• Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer

  2007cited by this paper
• Loss of androgen receptor binding to selective androgen response elements causes a reproductive phenotype in a knockin mouse model

  2007cited by this paper
• Comparison of crystal structures of human androgen receptor ligand‐binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity

  2006cited by this paper
• A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin.

  2006cited by this paper
• MUSTANG: A multiple structural alignment algorithm

  2006cited by this paper
• Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains.

  2006cited by this paper
• The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions.

  2005cited by this paper
• Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect

  2005cited by this paper
• The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells

  2005cited by this paper
• GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor

  2005cited by this paper
• Synthetic progestins used in HRT have different glucocorticoid agonist properties.

  2005cited by this paper
• Tetrahydrogestrinone is a potent androgen and progestin.

  2004cited by this paper
• Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor.

  2004cited by this paper
• Not all progestins are the same: implications for usage.

  2004cited by this paper
• Tissue-selectivity: the mechanism of action of tibolone.

  2004cited by this paper
• Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor

  2004cited by this paper
• Medroxyprogesterone acetate downregulates cytokine gene expression in mouse fibroblast cells.

  2004cited by this paper
• Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance.

  2004cited by this paper
• Receptor profiling and endocrine interactions of tibolone.

  2003cited by this paper
• Classification and pharmacology of progestins.

  2003cited by this paper
• The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.

  2003cited by this paper
• Breast cancer and hormone-replacement therapy in the Million Women Study.

  2003cited by this paper
• Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.

  2003cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• An investigation of the interactions of the androgen receptor with a non-steroidal compound and two synthetic progestins

  2002cited by this paper
• The FXXLF Motif Mediates Androgen Receptor-specific Interactions with Coregulators*

  2002cited by this paper
• A-Ring Reduced Metabolites of 19-nor Synthetic Progestins as Subtype Selective Agonists for ERα.

  2001cited by this paper
• A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha.

  2001cited by this paper
• 1α,25-Dihydroxyvitamin D3 Inhibits Prostate Cancer Cell Growth by Androgen-Dependent and Androgen-Independent Mechanisms.

  2000cited by this paper
• Hormonal properties of norethisterone, 7α-methyl-norethisterone and their derivatives

  2000cited by this paper
• FXXLF and WXXLF Sequences Mediate the NH2-terminal Interaction with the Ligand Binding Domain of the Androgen Receptor*

  2000cited by this paper
• Influence of the substitution of 11-methylene, delta(15), and/or 18-methyl groups in norethisterone on receptor binding, transactivation assays and biological activities in animals.

  2000cited by this paper
• 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.

  2000cited by this paper
• Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives.

  2000cited by this paper
• Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes.

  1999cited by this paper
• The Androgen Receptor Amino-Terminal Domain Plays a Key Role in p160 Coactivator-Stimulated Gene Transcription

  1999cited by this paper
• Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.

  1999cited by this paper
• Activation Function 2 in the Human Androgen Receptor Ligand Binding Domain Mediates Interdomain Communication with the NH2-terminal Domain*

  1999cited by this paper
• Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone.

  1999cited by this paper
• Specific Androgen Receptor Activation by an Artificial Coactivator*

  1999cited by this paper
• Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

  1998cited by this paper
• Mammalian two-hybrid system: a complementary approach to the yeast two-hybrid system.

  1997cited by this paper
• Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.

  1997cited by this paper
• The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.

  1996cited by this paper
• A and B forms of the androgen receptor are expressed in a variety of human tissues.

  1996cited by this paper
• Mutual Transcriptional Interference between RelA and Androgen Receptor*

  1996cited by this paper
• Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans.

  1995cited by this paper
• Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor.

  1995cited by this paper
• Evidence for an Anti-parallel Orientation of the Ligand-activated Human Androgen Receptor Dimer (*)

  1995cited by this paper
• Treatment of the Postmenopausal Woman: Basic and Clinical Aspects

  1994cited by this paper
• Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones.

  1992cited by this paper
• Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids.

  1990cited by this paper
• Gene regulation by steroid hormones.

  1989cited by this paper
• The human androgen receptor: domain structure, genomic organization and regulation of expression.

  1989cited by this paper
• The steroid and thyroid hormone receptor superfamily.

  1988cited by this paper
• Gene regulation by steroid hormones.

  1987cited by this paper
• Variability of pharmacokinetic parameters for contraceptive steroids.

  1983cited by this paper
• Binding of progestagens to receptor proteins in MCF-7 cells.

  1983cited by this paper
• Interaction of medroxyprogesterone acetate with cytosol androgen receptors in the rat hypothalamus and pituitary.

  1983cited by this paper
• Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma.

  1981cited by this paper
• Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer.

  1980cited by this paper
• Pharmacokinetics of norethindrone acetate in women.

  1979cited by this paper
• A radioimmunoassay for serum medroxyprogesterone acetate.

  1978cited by this paper
• Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate (Provera).

  1974cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• Breast cancer risk in peri- and postmenopausal women with a history of hormonal contraceptive use: A narrative review.

  2026cites this paper
• Injectable contraceptives differentially affect the hypothalamic-pituitary-gonadal axis and amenorrhea incidence†.

  2026cites this paper
• Contraception in transgender and gender diverse patients.

  2025cites this paper
• The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial

  2024cites this paper
• Progestagens and progesterone receptor modulation: Effects on the brain, mood, stress, and cognition in females.

  2024cites this paper
• Progestins and breast cancer hallmarks: The role of the ERK1/2 and JNK pathways in estrogen receptor positive breast cancer cells.

  2023influential citation
• Progesterone receptor isoform ratios influence the transcriptional activity of progestins via the progesterone receptor.

  2023cites this paper
• Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha

  2022cites this paper
• Differential off-target glucocorticoid activity of progestins used in endocrine therapy.

  2022cites this paper
• Irilone, a Red Clover Isoflavone, Combined with Progesterone Enhances PR Signaling through the Estrogen and Glucocorticoid Receptors.

  2021cites this paper
• The Flavonoid Baicalein Negatively Regulates Progesterone Target Genes in the Uterus in Vivo.

  2021cites this paper
• Antiandrogens and Androgen Inhibitors

  2021cites this paper
• Baicalein Is a Phytohormone that Signals Through the Progesterone and Glucocorticoid Receptors

  2020cites this paper
• Progestins in menopausal hormone therapy and breast cancer risk: The debate continues

  2020cites this paper
• Maraviroc, tenofovir disoproxil fumarate and dapivirine, activate progesterone receptor B in the absence progestogens.

  2020cites this paper
• Characterisation of progestins used in hormonal contraception and progesterone via the progesterone receptor.

  2020cites this paper
• Progesterone and abnormal uterine bleeding/menstrual disorders.

  2020cites this paper
• Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions

  2020cites this paper
• A direct comparison of the transcriptional activities of progestins used in contraception and menopausal hormone therapy via the mineralocorticoid receptor.

  2020cites this paper
• Progesterone and Breast Cancer: an NCI Workshop Report

  2020cites this paper
• Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women☆☆☆

  2019cites this paper
• Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms.

  2019cites this paper
• Thyroid function during the first year of use of the injectable contraceptive depot medroxyprogesterone acetate

  2019cites this paper
• The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations

  2019cites this paper
• In vitro effects of progesterone and the synthetic progestin medroxyprogesterone acetate on vascular remodeling.

  2019cites this paper
• Reciprocal Modulation of Antiretroviral Drug and Steroid Receptor Function In Vitro

  2019cites this paper
• ANTI-proliferative transcriptional effects of medroxyprogesterone acetate in Estrogen receptor positive breast cancer cells are predominantly mediated by ThE progesterone receptor.

  2019cites this paper
• Contamination levels and spatial distribution in the lagoons of the Po river delta: Are chemicals exerting toxic effects?

  2019cites this paper
• Hormone Therapy and Breast Cancer: Emerging Steroid Receptor Mechanisms.

  2018cites this paper
• The Role of Androgen Receptor Signalling in Endocrine Resistant Breast Cancer

  2018cites this paper
• The Flavonoid Apigenin Is a Progesterone Receptor Modulator with In Vivo Activity in the Uterus

  2018cites this paper
• Investigating the mechanism of action of hormones used in hormone replacement therapy via estrogen receptor subtypes and the influence of the progesterone receptor

  2018cites this paper
• Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels

  2018cites this paper
• Cross talk between the glucocorticoid receptor and the progesterone receptor in modulation of progestin responses and HIV-1 infection

  2018cites this paper
• Neurosteroid Metabolites of Gonadal Steroid Hormones in Neuroprotection: Implications for Sex Differences in Neurodegenerative Disease

  2018cites this paper
• Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity

  2018cites this paper
• Effect-directed analysis (EDA) of Danube River water sample receiving untreated municipal wastewater from Novi Sad, Serbia.

  2018cites this paper
• Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms

  2018cites this paper
• Investigating progesterone and estrogen receptor crosstalk in breast cancer

  2017cites this paper
• The metabolic fate and receptor interaction of 16α-hydroxyprogesterone and its 5α-reduced metabolite, 16α-hydroxy-dihydroprogesterone.

  2017cites this paper
• Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?

  2017cites this paper
• MEDROXYPROGESTERONE ACETATE HAS MINIMAL IMPACT ON HIV-1 REPLICATION IN ECTOCERVICAL TISSUE EX VIVO

  2017cites this paper
• A comparative characterization of estrogens used in hormone therapy via estrogen receptor (ER)-α and -β.

  2017cites this paper
• Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy.

  2017cites this paper
• 11-Ketotestosterone and 11-Ketodihydrotestosterone in Castration Resistant Prostate Cancer: Potent Androgens Which Can No Longer Be Ignored

  2016cites this paper
• Menopausal estrogen therapy and non‐Hodgkin's lymphoma: A post‐hoc analysis of women's health initiative randomized clinical trial

  2016cites this paper
• Fourth-Generation Progestins Inhibit 3β-Hydroxysteroid Dehydrogenase Type 2 and Modulate the Biosynthesis of Endogenous Steroids

  2016cites this paper
• The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception

  2015cites this paper
• Low-dose progestin-releasing contraceptives are associated with a higher pain threshold in healthy women.

  2015cites this paper
• Determinants of Receptor- and Tissue-Specific Actions in Androgen Signaling.

  2015cites this paper
• Differential effects of progestogens on HIV-1 replication and host gene expression in primary PBMCs and cervical tissue explants

  2015cites this paper
• Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature

  2014cites this paper
• Medroxyprogesterone Acetate Differentially Regulates Interleukin (IL)-12 and IL-10 in a Human Ectocervical Epithelial Cell Line in a Glucocorticoid Receptor (GR)-dependent Manner*

  2014cites this paper